Jason N Moore

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Vascular Endothelial Growth Factor

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Michael J Fusco, Sandra J Casak, Sirisha L Mushti, Joyce Cheng, Brian J Christmas, Matthew D Thompson, Wentao Fu, Hezhen Wang, Miyoung Yoon, Yuching Yang, Jason N Moore, Youwei Bi, Yang Nan, Craig E Long, Doris Auth, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Lola A Fashoyin-Aje, Paul G Kluetz, Steven J Lemery
FDA Approval Summary: Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, Joyce Cheng, Steven J Lemery, Yuan Li Shen, Wentao Fu, Jason N Moore, Yangbing Li, Youwei Bi, Doris Auth, Nataliya Fesenko, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Tucatinib with trastuzumab for advanced unresectable or metastatic, chemotherapy refractory, HER2 positive RAS wild type colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)